Ignite Creation Date:
2024-05-06 @ 7:02 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05872347
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2023-05-14
Brief Title:
Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases
Sponsor:
Shanghai Pharmaceuticals Holding Co Ltd
Organization:
Shanghai Pharmaceuticals Holding Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Cancer Brain Metastases |
Keywords: